News stories about Sigma-Aldrich (NASDAQ:SIAL) have trended somewhat negative recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sigma-Aldrich earned a news impact score of -0.14 on Accern’s scale. Accern also gave media coverage about the specialty chemicals company an impact score of 45.8125196415647 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

COPYRIGHT VIOLATION NOTICE: “Sigma-Aldrich (SIAL) Given Daily News Impact Rating of -0.14” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.watchlistnews.com/sigma-aldrich-sial-given-daily-news-impact-rating-of-0-14/1644505.html.

About Sigma-Aldrich

Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of biochemical and organic chemical products, kits and services that are used in scientific research. It manufactures and distributes around 250,000 chemicals, biochemical and other essential products and approximately 46,000 equipment products.

Insider Buying and Selling by Quarter for Sigma-Aldrich (NASDAQ:SIAL)

Receive News & Ratings for Sigma-Aldrich Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigma-Aldrich Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.